Skip to main content

Table 6 ICER results and their corresponding GDP per capita

From: Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Country

ICER

GDP per capita (USD)

Switzerland

40,505 EUR (45,950 USD) per LYG

57,579

United Kingdom

25,803 GBP (33,073 USD) per QALY

44,252

Sweden

41,500 USD per QALY

46,256

Norway

35,974 EUR (40,810 USD) per LYG

85,170

United States

26,417 USD per QALY

48,061

United States

39,892 USD per QALY

55,443